Journal
VIRUSES-BASEL
Volume 6, Issue 3, Pages 1015-1036Publisher
MDPI AG
DOI: 10.3390/v6031015
Keywords
West Nile virus; flavivirus; humoral immunity; neutralizing antibody; epitopes; therapeutics
Categories
Funding
- NIH [5R01AI098723]
Ask authors/readers for more resources
West Nile virus (WNV) has become the principal cause of viral encephalitis in North America since its introduction in New York in 1999. This emerging virus is transmitted to humans via the bite of an infected mosquito. While there have been several candidates in clinical trials, there are no approved vaccines or WNV-specific therapies for the treatment of WNV disease in humans. From studies with small animal models and convalescent human patients, a great deal has been learned concerning the immune response to infection with WNV. Here, we provide an overview of a subset of that information regarding the humoral and antibody response generated during WNV infection.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available